PDCD1 and neoplasm: Consistent with the observation in Figure 4J, anti–hPD-1H mAbs significantly decreased the size of tumors, but anti–hPD-1 mAbs did not suppress AML tumor growth (Figure 7 and Supplemental Figure 15).